Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine

Clinical trial NCT01964183 · COMPLETED

Trial details

NCT number: NCT01964183
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pharmacokinetics of Mirabegron and Tolterodine Healthy

Start date: 2013-06-01
Primary completion: 2013-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.